Shore P - Search Results

1

Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch.

Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, Boot-Handford RP, Shore P, Whitmarsh A, Dixon MJ. Richardson RJ, et al. Among authors: shore p. Nat Genet. 2006 Nov;38(11):1329-34. doi: 10.1038/ng1894. Epub 2006 Oct 15. Nat Genet. 2006. PMID: 17041603

2

Missense mutations that cause Van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6.

Little HJ, Rorick NK, Su LI, Baldock C, Malhotra S, Jowitt T, Gakhar L, Subramanian R, Schutte BC, Dixon MJ, Shore P. Little HJ, et al. Among authors: shore p. Hum Mol Genet. 2009 Feb 1;18(3):535-45. doi: 10.1093/hmg/ddn381. Epub 2008 Nov 26. Hum Mol Genet. 2009. PMID: 19036739 Free PMC article.

3

Integration of MAP kinase signal transduction pathways at the serum response element.

Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Whitmarsh AJ, et al. Among authors: shore p. Science. 1995 Jul 21;269(5222):403-7. doi: 10.1126/science.7618106. Science. 1995. PMID: 7618106

4

The DNA recognition subunit of a DNA methyltransferase is predominantly a molten globule in the absence of DNA.

Hornby DP, Whitmarsh A, Pinarbasi H, Kelly SM, Price NC, Shore P, Baldwin GS, Waltho J. Hornby DP, et al. Among authors: shore p. FEBS Lett. 1994 Nov 21;355(1):57-60. doi: 10.1016/0014-5793(94)01171-0. FEBS Lett. 1994. PMID: 7957963 Free article.

5

Determinants of DNA-binding specificity of ETS-domain transcription factors.

Shore P, Whitmarsh AJ, Bhaskaran R, Davis RJ, Waltho JP, Sharrocks AD. Shore P, et al. Mol Cell Biol. 1996 Jul;16(7):3338-49. doi: 10.1128/MCB.16.7.3338. Mol Cell Biol. 1996. PMID: 8668149 Free PMC article.

6

Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.

Mendoza-Villanueva D, Zeef L, Shore P. Mendoza-Villanueva D, et al. Among authors: shore p. Breast Cancer Res. 2011 Oct 27;13(5):R106. doi: 10.1186/bcr3048. Breast Cancer Res. 2011. PMID: 22032690 Free PMC article.

7

Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.

Bristow CA, Shore P. Bristow CA, et al. Among authors: shore p. Nucleic Acids Res. 2003 Jun 1;31(11):2735-44. doi: 10.1093/nar/gkg401. Nucleic Acids Res. 2003. PMID: 12771199 Free PMC article.

8

Runx Genes in Breast Cancer and the Mammary Lineage.

Rooney N, Riggio AI, Mendoza-Villanueva D, Shore P, Cameron ER, Blyth K. Rooney N, et al. Among authors: shore p. Adv Exp Med Biol. 2017;962:353-368. doi: 10.1007/978-981-10-3233-2_22. Adv Exp Med Biol. 2017. PMID: 28299668 Review.

9

Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1.

Shore P, Dietrich W, Corcoran LM. Shore P, et al. Nucleic Acids Res. 2002 Apr 15;30(8):1767-73. doi: 10.1093/nar/30.8.1767. Nucleic Acids Res. 2002. PMID: 11937630 Free PMC article.

10

A role for Runx2 in normal mammary gland and breast cancer bone metastasis.

Shore P. Shore P. J Cell Biochem. 2005 Oct 15;96(3):484-9. doi: 10.1002/jcb.20557. J Cell Biochem. 2005. PMID: 16052475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters